Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic Marker for Asthma Identified at Oxford

11.02.2003


Researchers at Oxford University’s Wellcome Trust Centre for Human Genetics have located a variant form of a polynucleotide sequence in the MHC region of chromosome 6p and identified its association with an increased secretion of TNF. Potential applications for this discovery include the diagnosis of asthma in patients, or a predisposition to asthma, and a patients’ suitability for treatment with anti-TNF therapy.



Asthma is a disease in which the airways become inflamed leading to blockage and narrowing, with resultant symptoms including wheezing, coughing, shortness of breath and tightening of the chest. Asthma sufferers can be of any race, age or sex, and over 17 million people in the United States alone suffer from the disease.

Most asthma is initiated by an IgE mediated allergy (atopy) to inhaled environmental allergens, including pollen, air pollutants and irritants. The susceptibility to asthma is strongly familial, and is due to both genetic and environmental factors. The identification of other genetic factors will lead to further understanding of susceptibility to asthma and an ability to develop a pharmacogenomic approach to treatment, new therapeutic approaches to treat sub-groups of patients who will benefit most from them. Tumour necrosis factor (TNF) is a potent pro-inflammatory cytokine that is found in increased concentrations in asthmatic airways and in lavage fluid from asthmatic lungs.


The Oxford research team has found that unusual genetic variants in or linked to the TNF? gene are predictive of asthma and inhaled or oral steroid usage in asthmatic individuals. This exciting new technology may be used as a diagnostic tool, useful to predict the clinical course of disease or the response to particular treatments, as well as helping to develop new therapeutic strategies.

Isis Innovation, Oxford University’s technology transfer company, has filed a patent application (US 09/058,165, 20010007741) and is actively seeking licensees to develop and commercialise this technology.

Jennifer Johnson | alfa
Further information:
http://www.isis-innovation.com/licensing/146.html

More articles from Health and Medicine:

nachricht Spread of deadly eye cancer halted in cells and animals
13.11.2018 | Johns Hopkins Medicine

nachricht Breakthrough in understanding how deadly pneumococcus avoids immune defenses
13.11.2018 | University of Liverpool

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A Chip with Blood Vessels

Biochips have been developed at TU Wien (Vienna), on which tissue can be produced and examined. This allows supplying the tissue with different substances in a very controlled way.

Cultivating human cells in the Petri dish is not a big challenge today. Producing artificial tissue, however, permeated by fine blood vessels, is a much more...

Im Focus: A Leap Into Quantum Technology

Faster and secure data communication: This is the goal of a new joint project involving physicists from the University of Würzburg. The German Federal Ministry of Education and Research funds the project with 14.8 million euro.

In our digital world data security and secure communication are becoming more and more important. Quantum communication is a promising approach to achieve...

Im Focus: Research icebreaker Polarstern begins the Antarctic season

What does it look like below the ice shelf of the calved massive iceberg A68?

On Saturday, 10 November 2018, the research icebreaker Polarstern will leave its homeport of Bremerhaven, bound for Cape Town, South Africa.

Im Focus: Penn engineers develop ultrathin, ultralight 'nanocardboard'

When choosing materials to make something, trade-offs need to be made between a host of properties, such as thickness, stiffness and weight. Depending on the application in question, finding just the right balance is the difference between success and failure

Now, a team of Penn Engineers has demonstrated a new material they call "nanocardboard," an ultrathin equivalent of corrugated paper cardboard. A square...

Im Focus: Coping with errors in the quantum age

Physicists at ETH Zurich demonstrate how errors that occur during the manipulation of quantum system can be monitored and corrected on the fly

The field of quantum computation has seen tremendous progress in recent years. Bit by bit, quantum devices start to challenge conventional computers, at least...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

“3rd Conference on Laser Polishing – LaP 2018” Attracts International Experts and Users

09.11.2018 | Event News

On the brain’s ability to find the right direction

06.11.2018 | Event News

European Space Talks: Weltraumschrott – eine Gefahr für die Gesellschaft?

23.10.2018 | Event News

 
Latest News

The dawn of a new era for genebanks - molecular characterisation of an entire genebank collection

13.11.2018 | Life Sciences

Fish recognize their prey by electric colors

13.11.2018 | Life Sciences

Ultrasound Connects

13.11.2018 | Awards Funding

VideoLinks
Science & Research
Overview of more VideoLinks >>>